AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
GH Research PLC Ordinary Shares
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG011BQC422
18.07▼ 0.43 (-2.32%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
—
EBITDA
—
Diluted EPS (TTM)
—
EBITDA Margin
—
Net Debt
—
Trading Information
Previous Close
18.50
Day's Range
17.54 – 18.59
52-Week Range
12.04 – 31.44
Volume
699.2K
Avg Volume
311.3K
Share Statistics
Shares Outstanding
Employees
56
Exchange
XNAS
Listed
2021-06-25
Share count as of December 31, 2025

GH Research PLC Ordinary Shares (GHRS) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about GH Research PLC Ordinary Shares (GHRS)
What is GH Research PLC Ordinary Shares's Market Cap?
GH Research PLC Ordinary Shares's Market Cap is $1.1B, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · GHRSAs-filed SEC (XBRL) data
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Operating expenses
Research and development
General and administration
Loss from operations
Finance income
Finance expense
Movement of expected credit loss
Foreign exchange gain/(loss)
Total other income
Loss before tax
Tax charge/(credit)
Loss for the year
Items that may be reclassified to profit or loss
Fair value movement on marketable securities
Currency translation adjustment
Total comprehensive loss for the year
Attributable to owners:
Loss for the year
Total comprehensive loss for the year
Loss per share
Basic loss per share (in dollars per share)
Diluted loss per share (in dollars per share)